The Danish Presidency of the Council of the EU wishes to stress that the Union must urgently promote research and development in the field of advanced therapy medicinal products (ATMPs), according to its draft conclusions on a ‘Call for action on life sciences for the Union’s competitiveness’, published on Wednesday 27 August.
At the beginning of July, the European Commission proposed to use its funding programmes to stimulate the acquisition of innovations through specific calls for...